We are live on ! Find out more
PCYC

PHARMACYCLICS INC
PCYC

Delisted

PCYC was delisted on the 22nd of May, 2015.

251 hedge funds and large institutions have $5.08B invested in PHARMACYCLICS INC in 2014 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 97 increasing their positions, 89 reducing their positions, and 58 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more repeat investments, than reductions

Existing positions increased: 97 | Existing positions reduced: 89

4% less capital invested

Capital invested by funds: $5.29B → $5.08B (-$210M)

10% less funds holding

Funds holding: 280251 (-29)

27% less call options, than puts

Call options by funds: $112M | Put options by funds: $154M

33% less funds holding in top 10

Funds holding in top 10: 96 (-3)

47% less first-time investments, than exits

New positions opened: 31 | Existing positions closed: 58

Holders
251
Holders Change
-29
Holders Change %
-10.36%
% of All Funds
7.21%
Holding in Top 10
6
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-33.33%
% of All Funds
0.17%
New
31
Increased
97
Reduced
89
Closed
58
Calls
$112M
Puts
$154M
Net Calls
-$41.6M
Net Calls Change
+$30.5M
Name Holding Trade Value Shares
Change
Change in
Stake
HCM
76
Highbridge Capital Management
New York
$4.6M -$429K -4,577 -8%
SFM
77
Sphera Funds Management
Israel
$4.49M +$4.69M +50,000 New
U
78
UBS
Switzerland
$4.1M -$865K -9,224 -17%
Citigroup
79
Citigroup
New York
$4.01M +$730K +7,777 +21%
State of Wisconsin Investment Board
80
State of Wisconsin Investment Board
Wisconsin
$3.99M +$253K +2,700 +6%
Wells Fargo
81
Wells Fargo
California
$3.96M -$137K -1,455 -3%
BlackRock
82
BlackRock
New York
$3.96M -$2.8M -29,796 -40%
AII
83
AGF Investments Inc
Ontario, Canada
$3.8M
PA
84
Profund Advisors
Maryland
$3.54M -$985K -10,501 -21%
VFA
85
Virtus Fund Advisers
Connecticut
$3.54M +$3.7M +39,448 New
TA
86
Teachers Advisors
New York
$3.46M -$3.22M -34,333 -47%
HCM
87
Harvey Capital Management
Florida
$2.97M +$4.69K +50 +0.2%
American Century Companies
88
American Century Companies
Missouri
$2.95M +$2.36M +25,106 +324%
Lord, Abbett & Co
89
Lord, Abbett & Co
New Jersey
$2.88M -$3.74M -39,809 -55%
ARC
90
Absolute Return Capital
Massachusetts
$2.83M +$2.96M +31,502 New
VOYA Investment Management
91
VOYA Investment Management
Georgia
$2.78M +$71.2K +759 +3%
DekaBank Deutsche Girozentrale
92
DekaBank Deutsche Girozentrale
Germany
$2.71M +$231K +2,465 +9%
FM
93
Forward Management
California
$2.71M +$2.78M +29,625 New
BIM
94
BlackRock Investment Management
Delaware
$2.66M +$159K +1,697 +6%
BRA
95
Bender Robert & Associates
California
$2.55M +$2.22M +23,649 +493%
MIG
96
Mariner Investment Group
New York
$2.52M +$1.6M +17,100 +155%
BCM
97
Bluefin Capital Management
New York
$2.4M +$778K +8,296 +45%
Asset Management One
98
Asset Management One
Japan
$2.33M +$365K +3,893 +17%
PP
99
Paloma Partners
Connecticut
$2.27M -$442K -4,706 -16%
PAMU
100
Pictet Asset Management (UK)
United Kingdom
$2.25M +$28.1K +300 +1%

PCYC Hedge Fund Activity: Q2 2014 in Review

251 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in PHARMACYCLICS INC (PCYC) for Q2 2014, worth a combined $5.08B — down 4% from $5.29B a quarter earlier.

Sellers outnumbered buyers: 58 funds closed out of PCYC and 31 opened new positions — a net loss of 27 holders — while 89 trimmed existing stakes and 97 added.

The largest buyer was Janus Henderson Investors US, adding an estimated $225M. The largest seller was Columbus Circle Investors, cutting an estimated $74.7M.

  • 251 institutional investors held PHARMACYCLICS INC (PCYC) as of Q2 2014, down from 280 in Q1 2014.
  • Funds reported $5.08B of PHARMACYCLICS INC stock for Q2 2014, down 4% quarter-over-quarter.
  • 31 funds opened new PHARMACYCLICS INC positions in Q2 2014 and 58 closed out, a net change of -27 holders.
  • The largest PHARMACYCLICS INC buyer in Q2 2014 was Janus Henderson Investors US, an estimated $225M added.
  • The largest PHARMACYCLICS INC seller in Q2 2014 was Columbus Circle Investors, an estimated $74.7M sold.

Based on aggregated 13F filings for Q2 2014.